You just read:

FDA Approves Amyvid™ (Florbetapir F 18 Injection) for Use in Patients Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Decline

News provided by

Eli Lilly and Company

Apr 09, 2012, 07:00 ET